Clinical outcomes with canagliflozin according to baseline body mass index: results from post hoc analyses of the CANVAS Program

AIMS: Sodium glucose co‐transporter 2 (SGLT2) inhibitors reduce several cardiovascular risk factors, including plasma glucose, blood pressure, albuminuria and body weight. Long‐term treatment lowers risks of cardiovascular and renal events. The objective of this post hoc analysis was to determine th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Diabetes Obes Metab
Hlavní autoři: Ohkuma, Toshiaki, Van Gaal, Luc, Shaw, Wayne, Mahaffey, Kenneth W., de Zeeuw, Dick, Matthews, David R., Perkovic, Vlado, Neal, Bruce
Médium: Artigo
Jazyk:Inglês
Vydáno: Blackwell Publishing Ltd 2020
Témata:
Original Articles
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7078821/
https://ncbi.nlm.nih.gov/pubmed/31729107
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/dom.13920
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky